A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.
Journal article published in PLoS Pathogens and co-authored by PATH's Randall MacGill, Emily Locke, and Siddhartha Dutta.
Publication date: November 2022